Dosimetric effects of composition, location and size of tissue heterogeneities on 252Cf neutron brachytherapy

被引:4
作者
Karimi-Shahri, Keyhandokht [1 ]
Izadi-Vasafi, Gholam Hossein [1 ]
Firoozabadi, Mohammad Mehdi [1 ]
Ghorbani, Mahdi [2 ]
机构
[1] Univ Birjand, Fac Sci, Dept Phys, Birjand, Iran
[2] Shahid Beheshti Univ Med Sci, Sch Med, Biomed Engn & Med Phys Dept, Tehran, Iran
关键词
Neutron brachytherapy; Cf-252; source; Heterogeneity; Dosimetry; Monte Carlo simulation; INTERSTITIAL BRACHYTHERAPY;
D O I
10.1016/j.apradiso.2021.109639
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The purpose of this study is to evaluate the effect of tissue heterogeneities on dose distribution in Californium-252 (Cf-252) neutron brachytherapy. The effect of location and size of heterogeneity on dose distribution was also evaluated. Neutron and photon dose rate distributions were determined in a water phantom in presence of air, lung, soft tissue and bone heterogeneities using MCNPX code. To benchmark the Monte Carlo simulation of the Cf-252 source, air kerma strength (S-KN), dose rate constant (A(N)) and radial dose function (g(N)(r)) were calculated and compared with previously reported data. Results showed a considerable reduction of neutron dose rate (up to 66%) inside heterogeneities, especially in air and bone heterogeneities, while the reduction of total photon dose rate was found less significant (up to 10%). In the presence of a heterogeneity, dose rate, fluence and energy spectrum were significantly different with respect to the homogenous phantom. The contribution of photon dose to the total dose in the presence of air and bone was dominant, compared to the neutron dose, whereas this photon contribution was reduced after passing the heterogeneity. As the bone heterogeneity size was increased from 1 x 1 x 1 cm(3) to 1 x 3 x 1 cm(3), the total dose and neutron energy fluence decreased of about 50% and 70%, respectively.
引用
收藏
页数:8
相关论文
共 25 条
[11]  
Maruyama Y., 1986, ENDOCRINE HYPERTHERM, V2, P171
[12]   EFFECTIVE ATTENUATION IN WATER OF GAMMA RAYS OF GOLD 198 IRIDIUM 192 CESIUM 137 RADIUM 226 AND COBALT 60 [J].
MEISBERGER, LL ;
KELLER, RJ ;
SHALEK, RJ .
RADIOLOGY, 1968, 90 (05) :953-+
[13]   DOSIMETRY OF INTERSTITIAL BRACHYTHERAPY SOURCES - RECOMMENDATIONS OF THE AAPM RADIATION-THERAPY COMMITTEE TASK GROUP NO 43 [J].
NATH, R ;
ANDERSON, LL ;
LUXTON, G ;
WEAVER, KA ;
WILLIAMSON, JF ;
MEIGOONI, AS .
MEDICAL PHYSICS, 1995, 22 (02) :209-234
[14]   Neutrons absorbed dose rate calculations for interstitial brachytherapy with 252Cf sources [J].
Paredes, L. ;
Azorin, J. ;
Balcazar, M. ;
Francois, J. L. .
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2007, 580 (01) :582-585
[15]  
Pelowitz D. B., 2008, LACP071473 LOS AL NA
[16]   Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations [J].
Rivard, MJ ;
Coursey, BM ;
DeWerd, LA ;
Hanson, WF ;
Huq, MS ;
Ibbott, GS ;
Mitch, MG ;
Nath, R ;
Williamson, JF .
MEDICAL PHYSICS, 2004, 31 (03) :633-674
[17]   Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol [J].
Rivard, MJ ;
Wierzbicki, JG ;
Van den Heuvel, F ;
Martin, RC ;
McMahon, RR .
MEDICAL PHYSICS, 1999, 26 (01) :87-96
[18]  
Shahri KK, 2011, HELL J NUCL MED, V14, P110
[19]  
Song G., 2008, 2 INT C BIOINF BIOM, P16
[20]  
Srivastava R., 2014, Int. J. Contemp. Med. Res, V1, P61